Case Report: JAK inhibitors for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis with spontaneous pneumomediastinum
JAK inhibitors appear to be an efficient therapeutic option in the treatment of anti-MDA5-positive DM with SPNM.
Authors
- Xiaoguang Cui (ORCID: https://orcid.org/0009-0005-7689-5239)
- Xueyi Li (ORCID: https://orcid.org/0000-0003-2358-5171)
- Xin Yang (ORCID: https://orcid.org/0000-0002-7343-8412)
Institutions
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-09-02
- DOI
- https://doi.org/10.3389/fmed.2025.1642484
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00